Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
55.34B | 52.98B | 46.79B | 37.69B | 31.66B | 37.27B | Gross Profit |
16.95B | 14.99B | 11.52B | 10.44B | 9.85B | 11.77B | EBIT |
4.66B | 3.62B | 1.05B | 894.00M | 1.09B | 2.21B | EBITDA |
6.79B | 5.90B | 3.12B | 2.78B | 2.79B | 4.00B | Net Income Common Stockholders |
3.90B | 3.01B | 898.00M | 273.00M | 978.00M | 1.91B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
13.35B | 12.34B | 8.03B | 7.26B | 8.08B | 7.16B | Total Assets |
63.72B | 62.17B | 56.28B | 51.09B | 48.37B | 47.32B | Total Debt |
6.12B | 6.59B | 7.57B | 6.29B | 6.93B | 6.09B | Net Debt |
-7.23B | -4.39B | -457.00M | -962.00M | -1.14B | -1.07B | Total Liabilities |
19.49B | 19.54B | 19.30B | 17.22B | 16.20B | 15.45B | Stockholders Equity |
41.53B | 40.20B | 34.65B | 31.44B | 30.13B | 29.80B |
Cash Flow | Free Cash Flow | ||||
0.00 | 3.60B | -382.00M | -119.00M | 852.00M | 1.95B | Operating Cash Flow |
0.00 | 4.30B | 174.00M | 294.00M | 1.57B | 2.83B | Investing Cash Flow |
0.00 | 413.00M | 59.00M | -733.00M | -555.00M | -1.11B | Financing Cash Flow |
0.00 | -1.60B | -83.00M | -1.42B | 208.00M | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥27.55B | 6.37 | 4.84% | 4.77% | 43.74% | ||
80 Outperform | ¥20.17B | 7.42 | 4.03% | 8.23% | 37.45% | ||
79 Outperform | ¥131.81B | 11.34 | 1.95% | 17.86% | 39.28% | ||
77 Outperform | ¥165.56B | 10.88 | 4.72% | 0.50% | -8.77% | ||
72 Outperform | ¥24.99B | 10.04 | 1.90% | 11.95% | 68.61% | ||
61 Neutral | ¥4.29B | 32.70 | 1.34% | 5.14% | 1.96% | ||
51 Neutral | $2.02B | -1.14 | -21.36% | 3.64% | 2.88% | -30.57% |
Yushiro Chemical Industry Co., Ltd. reported a notable increase in its financial performance for the nine months ending December 31, 2024, with a 5.9% rise in net sales and a significant boost in operating profit by 34.6% compared to the previous year. The company forecasts continued growth with expected increases in net sales and profits for the fiscal year ending March 31, 2025, indicating a positive outlook for stakeholders and reinforcing its industry positioning.